特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
952920

トランスフェクションテクノロジー市場: 世界の業界動向、シェア、規模、成長、機会、予測(2020年~2025年)

Transfection Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 112 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.70円
トランスフェクションテクノロジー市場: 世界の業界動向、シェア、規模、成長、機会、予測(2020年~2025年)
出版日: 2020年07月18日
発行: IMARC Services Private Limited
ページ情報: 英文 112 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のトランスフェクションテクノロジー市場は、2014~2019年に約9%のCAGRで成長しました。トランスフェクションテクノロジーとは、デオキシリボ核酸(DNA)、リボ核酸(RNA)、オリゴヌクレオチドなどの核酸を人工的に細胞に導入するプロセスを指します。これは、物理的、化学的、生物学的方法を使用して導入されるもので、細胞の特定の特性を修正するのに役立ちます。共トランスフェクション、エレクトロポレーション、カチオン性脂質トランスフェクション、生体内トランスフェクションなど、さまざまな方法があります。このプロセスは、ウイルスやタンパク質の生物学的生産とともに、遺伝子発現、スクリーニング、RNA干渉、生体内調査などのさまざまなゲノム研究で一般的に使用されています。

癌やさまざまな慢性生活習慣病の有病率が上昇していることが、市場の成長を牽引する重要な要素の1つとなっています。さらに、試薬ベースの手法が広く採用されていることも、市場の成長を後押ししています。従来から使用されている手法と比較して、試薬ベースのトランスフェクションは管理が簡単で、費用対効果が高くなります。これに伴い、バイオリスティックテクノロジー、マイクロインジェクション、レーザーフェクションなどの機器ベースの手法も、世界中で大きな牽引力を獲得しています。細胞研究および治療創薬におけるさまざまな技術的進歩なども、市場の成長促進因子として機能しています。これに伴い、遺伝子導入の研究は、新規治療薬の開発やその他のさまざまな用途のために、主に生体内で行われています。大規模なトランスフェクション施設を開発するための政府や民間組織双方による増資も、タンパク質治療薬分野における広範な研究開発 (R&D)活動とともに、市場をさらに推進すると予測されています。今後の見通しとして、世界のトランスフェクションテクノロジー市場は今後5年間、穏やかな成長を続けるとみられています。

当レポートでは、世界のトランスフェクションテクノロジー市場について調査し、市場の概要とともに、製品タイプ別、用途別、トランスフェクション手法別、テクノロジー別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のトランスフェクションテクノロジー市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響

第6章 製品タイプ別市場内訳

  • 試薬
  • 計器
  • その他

第7章 用途別市場内訳

  • 治療デリバリー
  • 生物医学研究
  • タンパク質生成
  • その他

第8章 トランスフェクション手法別市場内訳

  • リポフェクション
  • エレクトロポレーション
  • ヌクレオフェクション
  • 共トランスフェクション
  • カチオン性脂質トランスフェクション
  • 生体内トランスフェクション
  • その他

第9章 テクノロジー別市場内訳

  • 物理的トランスフェクション
  • 生化学ベースのトランスフェクション
  • ウイルスベクターベースのトランスフェクション

第10章 エンドユーザー別市場内訳

  • 研究センター・学術機関
  • 病院・診療所
  • 製薬会社・バイオテクノロジー企業
  • その他

第11章 地域別市場内訳

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別市場内訳

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 競合情勢

  • 市場構造
  • キープレイヤー
  • キープレイヤーのプロファイル
    • Agilent Technologies Inc.
    • Bio-RAD Laboratories Inc.
    • Lonza Group AG
    • Maxcyte Inc.
    • Mirus Bio LLC
    • Polyplus Transfection
    • Promega Corporation
    • Roche Holding AG
    • Sigma-Aldrich Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Transfection Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Technologies Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Transfection Technologies Market: Breakup by Product Type (in %), 2019
  • Figure 4: Global: Transfection Technologies Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Transfection Technologies Market: Breakup by Transfection Method (in %), 2019
  • Figure 6: Global: Transfection Technologies Market: Breakup by Technology (in %), 2019
  • Figure 7: Global: Transfection Technologies Market: Breakup by End-User (in %), 2019
  • Figure 8: Global: Transfection Technologies Market: Breakup by Region (in %), 2019
  • Figure 9: Global: Transfection Technologies Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 10: Global: Transfection Technologies (Reagent) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Transfection Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Transfection Technologies (Instrument) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Transfection Technologies (Instrument) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Transfection Technologies (Therapeutic Delivery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Transfection Technologies (Therapeutic Delivery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Transfection Technologies (Bio-Medical Research) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Transfection Technologies (Bio-Medical Research) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Transfection Technologies (Protein Production) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Transfection Technologies (Protein Production) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Transfection Technologies (Lipofection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Transfection Technologies (Lipofection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Transfection Technologies (Eletroporation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Transfection Technologies (Eletroporation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Transfection Technologies (Nucleofection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Transfection Technologies (Nucleofection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: Global: Transfection Technologies (Cotransfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: Global: Transfection Technologies (Cotransfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: Global: Transfection Technologies (Cationic Lipid Transfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: Global: Transfection Technologies (Cationic Lipid Transfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Global: Transfection Technologies (In-Vivo Transfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Global: Transfection Technologies (In-Vivo Transfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: Global: Transfection Technologies (Physical Transfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: Global: Transfection Technologies (Physical Transfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Global: Transfection Technologies (Biochemical Based Transfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Global: Transfection Technologies (Biochemical Based Transfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: Global: Transfection Technologies (Viral-Vector Based Transfection) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: Global: Transfection Technologies (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: Global: Transfection Technologies (Research Centers and Academic Institutes) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: Global: Transfection Technologies (Research Centers and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Global: Transfection Technologies (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Global: Transfection Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Global: Transfection Technologies (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: North America: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: North America: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: United States: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: United States: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: Canada: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: Canada: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: Asia Pacific: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: Asia Pacific: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: China: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: China: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Japan: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Japan: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: India: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: India: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: South Korea: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: South Korea: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Australia: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Australia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Indonesia: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Indonesia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Others: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Europe: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Europe: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Germany: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Germany: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: France: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 79: France: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 80: United Kingdom: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 81: United Kingdom: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 82: Italy: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 83: Italy: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 84: Spain: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 85: Spain: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 86: Russia: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 87: Russia: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 88: Others: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 89: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 90: Latin America: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 91: Latin America: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 92: Brazil: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 93: Brazil: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 94: Mexico: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 95: Mexico: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 96: Others: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 97: Others: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 98: Middle East and Africa: Transfection Technologies Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 99: Middle East and Africa: Transfection Technologies Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 100: Global: Transfection Technologies Industry: SWOT Analysis
  • Figure 101: Global: Transfection Technologies Industry: Value Chain Analysis
  • Figure 102: Global: Transfection Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Technologies Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Transfection Technologies Market Forecast: Breakup by Product Type (in Million US$), 2020-2025
  • Table 3: Global: Transfection Technologies Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 4: Global: Transfection Technologies Market Forecast: Breakup by Transfection Method (in Million US$), 2020-2025
  • Table 5: Global: Transfection Technologies Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 6: Global: Transfection Technologies Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 7: Global: Transfection Technologies Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 8: Global: Transfection Technologies Market Structure
  • Table 9: Global: Transfection Technologies Market: Key Players
目次
Product Code: SR1019K54_Report

The global transfection technologies market grew at a CAGR of around 9% during 2014-2019. Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further. Looking forward, IMARC Group expects the global transfection technologies market to continue its moderate growth during the next five years.

Breakup by Product Type:

  • Reagent
  • Instrument
  • Others

Breakup by Application:

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method:

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology:

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End-User:

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global transfection technologies market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the transfection technologies market?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the transfection method?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global transfection technologies market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bio-Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Protein Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Transfection Method

  • 8.1 Lipofection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eletroporation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nucleofection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cotransfection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Cationic Lipid Transfection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 In-Vivo Transfection
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Physical Transfection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Based Transfection
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Viral-Vector Based Transfection
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Centers and Academic Institutes
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bio-RAD Laboratories Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Lonza Group AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Maxcyte Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.5 Mirus Bio LLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Polyplus Transfection
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Promega Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Roche Holding AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Sigma-Aldrich Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.